エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
July 11, 2024
AEHR TEST SYSTEMS |
(Exact name of registrant as specified in its charter) |
California |
|
000-22893 |
|
94-2424084 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
| ||||
|
400 KATO TERRACE FREMONT, CA 94539 | ||||
(Address of principal executive offices, including zip code) | ||||
| ||||
510-623-9400 | ||||
(Registrant’s telephone number, including area code) | ||||
| ||||
N/A | ||||
(Former name or former address, if changed since last report) | ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value $0.01 per share |
AEHR |
The NASDAQ Capital Market |
Item 2.02. Results of Operations and Financial Condition.
On July 16, 2024, Aehr Test Systems, a California corporation (the “Company”), issued a press release announcing the Company’s financial results for its fiscal 2024 fourth quarter and full year ended on May 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On July 11, 2024, the Board of Directors of the “Company approved a change in the Company’s fiscal year end from May 31 to a 4-4-5 fiscal calendar ending on the Friday closest to May 31. The first fiscal year under the new calendar will begin on June 1, 2024, and end on May 30, 2025. This change is expected to improve the comparability of the Company’s financial results between periods.
The change in fiscal year will not impact the Company’s previously issued financial statements or tax reporting.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
Description |
|
|
|
|
||
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AEHR TEST SYSTEMS | |||
| Date: July 16, 2024 | By: | /s/ Chris P. Siu | |
|
|
Name Chris P. Siu | |
| Executive Vice President of Finance and | |||
| Chief Financial Officer and Secretary | |||
| 3 |
EXHIBIT 99.1
| Contacts: |
|
|
|
|
|
|
| Aehr Test Systems |
| MKR Investor Relations Inc. |
| Chris Siu |
| Todd Kehrli or Jim Byers |
| Chief Financial Officer |
| Analyst/Investor Contact |
| csiu@aehr.com |
| (323) 468-2300 |
|
|
| aehr@mkr-group.com |
Aehr Test Systems Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results
and Provides Fiscal 2025 Full Year Financial Guidance
Fremont, CA (July 16, 2024) – Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its fiscal 2024 fourth quarter and full year ended May 31, 2024.
Fiscal Fourth Quarter Financial Results:
|
| · | Net revenue was $16.6 million, compared to $22.3 million in the fourth quarter of fiscal 2023 |
|
| · | GAAP net income was $23.9 million, or $0.81 per diluted share, which includes the impact of a tax benefit resulting from the release of the Company’s full income tax valuation allowance of approximately $20.8 million, compared to GAAP net income of $6.1 million, or $0.21 per diluted share, in the fourth quarter of fiscal 2023. |
|
| · | Non-GAAP net income was $24.7 million, or $0.84 per diluted share, which includes the tax benefit and excludes acquisition related costs and the impact of stock-based compensation, compared to non-GAAP net income of $6.8 million, or $0.23 per diluted share, in the fourth quarter of fiscal 2023. |
|
| · | Bookings were $4.0 million for the quarter |
|
| · | Backlog as of May 31, 2024, was $7.3 million. Effective backlog, which includes all orders received since the end of the fourth quarter, is $20.8 million. |
|
| · | Total cash and cash equivalents as of May 31, 2024 were $49.2 million, up from $47.6 million at February 29, 2024 |
Fiscal Year Financial Results:
|
| · | Net revenue was a record $66.2 million, compared to $65.0 million in fiscal 2023 |
|
| · | GAAP net income was $33.2 million, or $1.12 per diluted share, which includes the impact of a tax benefit resulting from the release of the Company’s full income tax valuation allowance of approximately $20.8 million recognized in the fourth quarter, compared to GAAP net income of $14.6 million, or $0.50 per diluted share, in fiscal 2023. |
|
| · | Non-GAAP net income, which includes the tax benefit and excludes acquisition related costs and the impact of stock-based compensation, was $35.8 million, or $1.21 per diluted share, compared to non-GAAP net income of $17.3 million, or $0.59 per diluted share, in fiscal 2023. |
An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr’s non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 2 of 8
Gayn Erickson, President and CEO of Aehr Test Systems, commented:
“Our full-year revenue and net income results exceeded our previously provided guidance and surpassed analyst consensus. Although we saw customer pushouts of silicon carbide devices due to slower electric vehicle (EV) demand in the second half of our fiscal year, we achieved another record year for annual revenue for Aehr.
“Wafer level test and burn-in of silicon carbide power semiconductors used in EVs was a key driver of our business in the last year, and we anticipate silicon carbide will continue to be a key contributor to revenue in the current fiscal year and beyond. To that point, we announced today that we received $12.7 million in orders from one of our silicon carbide test and burn-in customers for FOX WaferPak™ full wafer Contactors to support production of silicon carbide power devices for electric vehicles to be delivered over the next three months.
“The silicon carbide market continues to be an enormous opportunity for Aehr as we see more auto suppliers committed to silicon carbide in their EVs, as well as roadmaps that are based on modules for their electric motor power inverters. By 2030, battery EVs are forecasted to more than triple last year’s sales to 30 million or 30% of total vehicles manufactured worldwide.
“We remain actively engaged with a significant number of new silicon carbide device and module suppliers and seek to meet their anticipated capacity coming online beginning in 2025. We are also seeing growing demand for silicon carbide devices beyond the EV market, such as solar, data center, and other industrial applications for power conversion. We believe we are well positioned to continue to grow our business in silicon carbide, and we expect to receive first orders from a significant number of additional silicon carbide customers by the end of this fiscal year.
“We are also seeing traction with several emerging opportunities for our test and burn-in solutions in new target markets and expect bookings and revenue across a much broader range of customers and markets this fiscal year.
“One of the key new market opportunities we are focusing on is the growing demand for Artificial Intelligence (AI) processor test and burn-in at both the wafer level and the packaged part level.
“We are currently working with an AI accelerator company and have secured a commitment from them to evaluate our FOX solution for use in production wafer level burn-in of their high-power processors. Upon successful demonstration of wafer level test results and throughput, we expect they will utilize our new high-power FOX-XP systems for production of their next generation AI processors, starting this fiscal year.
“We also announced today in a separate press release our acquisition of Incal Technology, a manufacturer of highly acclaimed reliability test and burn-in solutions of a wide range of semiconductor devices and markets, with a new product family of ultra-high-power test solutions for AI accelerators, graphics & network processors, and high-performance computing processors. We believe that between wafer level and package part, the reliability test and production burn-in market for AI processors exceeds $100 million annually, and with this combined product portfolio we believe we have the opportunity to capture a meaningful share of the market this fiscal year.
“This past year we announced our first order for a FOX wafer level test and burn-in system for gallium nitride (GaN) devices. While silicon carbide will be the semiconductor material of choice for EV traction inverters, GaN is expected to gain significant penetration in the on-board charging market as well as other automotive, solar, and data center power conversion applications. We are working with several of the GaN market leaders, and received a significant number of WaferPak orders throughout the year for gallium nitride reliability test and qualification. We have now received our first forecasts for wafer level production burn-in systems to be delivered during this fiscal year. We continue to be encouraged by this market and believe it will be significant in market size for semiconductors and has the potential to be a solid market opportunity for Aehr’s solutions.
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 3 of 8
“Within the silicon photonics market, we shipped the first order from a major silicon photonics customer for the new high-power configuration of our FOX-XP system this last fiscal year. This new configuration expands our market opportunity by enabling cost-effective volume production test of wafers of next-generation photonic ICs that are targeted for use in the new optical I/O or co-packaged optics market. Nvidia, AMD, and Intel have all discussed the potential for adding optical chip-to-chip communication for performance improvement and power savings for AI processors and High-Performance Computing chips.
“Looking ahead, we believe Aehr has significant opportunities for growth in fiscal 2025 and beyond with our industry-leading product portfolio, and we look forward to updating you on our progress throughout the year as we seek to capitalize on these exciting new opportunities.”
Fiscal 2025 Financial Guidance:
For the fiscal year ending May 30, 2025, Aehr expects total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.
Management Conference Call and Webcast:
Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its fiscal 2024 fourth quarter and full year operating results. To access the live call, dial +1 888-506-0062 (US and Canada) or +1 973-528-0011 (International) and give the participant passcode 196310.
In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and may also be accessed by clicking here. A phone replay of the conference call will also be available beginning approximately two hours after conclusion of the live call and will remain available for one week. To access the call replay, dial +1 877-481-4010 (US and Canada) or +1 919-882-2331 (International) and enter replay passcode 50772.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer level, singulated die, and package part form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. For more information, please visit Aehr Test Systems’ website at www.aehr.com.
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 4 of 8
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates,” “going to,” "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr’s new and existing customers; bookings and revenue forecasted for proprietary WaferPakTM and DiePak consumables, as well as the ability to generate bookings and revenue from application of Aehr’s solutions in emerging markets; Aehr’s ability to receive orders and generate revenue in the future, as well as Aehr’s beliefs regarding the factors impacting the foregoing; preliminary financial guidance for the full fiscal year 2024; and expectations related to long-term demand for Aehr’s products, the attractiveness of key markets and the ability for AEHR to successfully enter new markets. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
– Financial Tables to Follow –
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 5 of 8
|
|
| Three Months Ended |
|
| Year Ended |
|
||||||||||||||
|
|
| May 31, |
|
| Feb 29, |
|
| May 31, |
|
| May 31, |
|
| May 31, |
|
|||||
| (In thousands, except per share data) |
| 2024 |
|
| 2024 |
|
| 2023 |
|
| 2024 |
|
| 2023 |
|
|||||
| Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
| Product |
| $ | 15,805 |
|
| $ | 6,730 |
|
| $ | 21,002 |
|
| $ | 61,729 |
|
| $ | 60,717 |
|
| Services |
|
| 795 |
|
|
| 833 |
|
|
| 1,267 |
|
|
| 4,489 |
|
|
| 4,244 |
|
| Total revenue |
|
| 16,600 |
|
|
| 7,563 |
|
|
| 22,269 |
|
|
| 66,218 |
|
|
| 64,961 |
|
| Cost of revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Product (1) |
|
| 7,519 |
|
|
| 3,948 |
|
|
| 10,020 |
|
|
| 31,093 |
|
|
| 29,759 |
|
| Services (1) |
|
| 633 |
|
|
| 459 |
|
|
| 770 |
|
|
| 2,582 |
|
|
| 2,456 |
|
| Total cost of revenue |
|
| 8,152 |
|
|
| 4,407 |
|
|
| 10,790 |
|
|
| 33,675 |
|
|
| 32,215 |
|
| Gross profit |
|
| 8,448 |
|
|
| 3,156 |
|
|
| 11,479 |
|
|
| 32,543 |
|
|
| 32,746 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development |
|
| 2,151 |
|
|
| 2,139 |
|
|
| 2,253 |
|
|
| 8,719 |
|
|
| 7,134 |
|
| Selling, general and administrative |
|
| 3,756 |
|
|
| 3,063 |
|
|
| 3,587 |
|
|
| 13,746 |
|
|
| 12,237 |
|
| Total operating expenses |
|
| 5,907 |
|
|
| 5,202 |
|
|
| 5,840 |
|
|
| 22,465 |
|
|
| 19,371 |
|
| Income (loss) from operations |
|
| 2,541 |
|
|
| (2,046 | ) |
|
| 5,639 |
|
|
| 10,078 |
|
|
| 13,375 |
|
| Interest income, net |
|
| 592 |
|
|
| 584 |
|
|
| 487 |
|
|
| 2,388 |
|
|
| 1,245 |
|
| Other expense, net |
|
| (10 | ) |
|
| (2 | ) |
|
| (4 | ) |
|
| (8 | ) |
|
| (3 | ) |
| Income (loss) before income tax expense (benefit) |
|
| 3,123 |
|
|
| (1,464 | ) |
|
| 6,122 |
|
|
| 12,458 |
|
|
| 14,617 |
|
| Income tax expense (benefit) |
|
| (20,741 | ) |
|
| 7 |
|
|
| 11 |
|
|
| (20,698 | ) |
|
| 60 |
|
| Net income (loss) |
| $ | 23,864 |
|
| $ | (1,471 | ) |
| $ | 6,111 |
|
| $ | 33,156 |
|
| $ | 14,557 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
| $ | 0.82 |
|
| $ | (0.05 | ) |
| $ | 0.21 |
|
| $ | 1.15 |
|
| $ | 0.52 |
|
| Diluted |
| $ | 0.81 |
|
| $ | (0.05 | ) |
| $ | 0.21 |
|
| $ | 1.12 |
|
| $ | 0.50 |
|
| Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
| 28,953 |
|
|
| 28,866 |
|
|
| 28,425 |
|
|
| 28,818 |
|
|
| 27,785 |
|
| Diluted |
|
| 29,459 |
|
|
| 28,866 |
|
|
| 29,572 |
|
|
| 29,617 |
|
|
| 29,215 |
|
(1) Certain amounts in a prior period have been reclassified to conform to the current period presentation.
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 6 of 8
AEHR TEST SYSTEMS
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited)
|
|
| Three Months Ended |
|
| Year Ended |
|
||||||||||||||
|
|
| May 31, |
|
| Feb 29, |
|
| May 31, |
|
| May 31, |
|
| May 31, |
|
|||||
| (In thousands, except per share data) |
| 2024 |
|
| 2024 |
|
| 2023 |
|
| 2024 |
|
| 2023 |
|
|||||
| Reconciliation of GAAP to non-GAAP gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
| GAAP gross profit |
| $ | 8,448 |
|
| $ | 3,156 |
|
| $ | 11,479 |
|
| $ | 32,543 |
|
| $ | 32,746 |
|
| Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| a) Stock-based compensation expense |
|
| 108 |
|
|
| 58 |
|
|
| 79 |
|
|
| 330 |
|
|
| 331 |
|
| Non-GAAP gross profit |
| $ | 8,556 |
|
| $ | 3,214 |
|
| $ | 11,558 |
|
| $ | 32,873 |
|
| $ | 33,077 |
|
| Reconciliation of GAAP to non-GAAP operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP operating expenses |
| $ | 5,907 |
|
| $ | 5,202 |
|
| $ | 5,840 |
|
| $ | 22,465 |
|
| $ | 19,371 |
|
| Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| a) Stock-based compensation expense |
|
| (667 | ) |
|
| (525 | ) |
|
| (574 | ) |
|
| (2,188 | ) |
|
| (2,417 | ) |
| b) Acquisition related costs |
|
| (107 | ) |
|
| - |
|
|
| - |
|
|
| (107 | ) |
|
| - |
|
| Non-GAAP operating expenses |
| $ | 5,133 |
|
| $ | 4,677 |
|
| $ | 5,266 |
|
| $ | 20,170 |
|
| $ | 16,954 |
|
| Reconciliation of GAAP to non-GAAP income (loss) from operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP income (loss) from operations |
| $ | 2,541 |
|
| $ | (2,046 | ) |
| $ | 5,639 |
|
| $ | 10,078 |
|
| $ | 13,375 |
|
| Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| a) Stock-based compensation expense |
|
| 775 |
|
|
| 583 |
|
|
| 653 |
|
|
| 2,518 |
|
|
| 2,748 |
|
| b) Acquisition related costs |
|
| 107 |
|
|
| - |
|
|
| - |
|
|
| 107 |
|
|
| - |
|
| Non-GAAP (loss) income from operations |
| $ | 3,423 |
|
| $ | (1,463 | ) |
| $ | 6,292 |
|
| $ | 12,703 |
|
| $ | 16,123 |
|
| Reconciliation of GAAP to non-GAAP income (loss) before income tax expense (benefit) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP income (loss) before income tax expense (benefit) |
| $ | 3,123 |
|
| $ | (1,464 | ) |
| $ | 6,122 |
|
| $ | 12,458 |
|
| $ | 14,617 |
|
| Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| a) Stock-based compensation expense |
|
| 775 |
|
|
| 583 |
|
|
| 653 |
|
|
| 2,518 |
|
|
| 2,748 |
|
| b) Acquisition related costs |
|
| 107 |
|
|
| - |
|
|
| - |
|
|
| 107 |
|
|
| - |
|
| Non-GAAP income (loss) before income tax expense (benefit) |
| $ | 4,005 |
|
| $ | (881 | ) |
| $ | 6,775 |
|
| $ | 15,083 |
|
| $ | 17,365 |
|
| Reconciliation of GAAP to non-GAAP net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP net income (loss) |
| $ | 23,864 |
|
| $ | (1,471 | ) |
| $ | 6,111 |
|
| $ | 33,156 |
|
| $ | 14,557 |
|
| Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| a) Stock-based compensation expense |
|
| 775 |
|
|
| 583 |
|
|
| 653 |
|
|
| 2,518 |
|
|
| 2,748 |
|
| b) Acquisition related costs |
|
| 107 |
|
|
| - |
|
|
| - |
|
|
| 107 |
|
|
| - |
|
| Non-GAAP net income (loss) |
| $ | 24,746 |
|
| $ | (888 | ) |
| $ | 6,764 |
|
| $ | 35,781 |
|
| $ | 17,305 |
|
| Reconciliation of GAAP net income (loss) per diluted share to non-GAAP net income (loss) per diluted share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP net income (loss) per diluted share |
| $ | 0.81 |
|
| $ | (0.05 | ) |
| $ | 0.21 |
|
| $ | 1.12 |
|
| $ | 0.50 |
|
| Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| a) Stock-based compensation expense |
|
| 0.03 |
|
|
| 0.02 |
|
|
| 0.02 |
|
|
| 0.09 |
|
|
| 0.09 |
|
| b) Acquisition related costs |
|
| 0.00 |
|
|
| - |
|
|
| - |
|
|
| 0.00 |
|
|
| - |
|
| Non-GAAP net income (loss) per diluted share |
| $ | 0.84 |
|
| $ | (0.03 | ) |
| $ | 0.23 |
|
| $ | 1.21 |
|
| $ | 0.59 |
|
a) Represents compensation expense for equity awards granted to employees and directors
b) Represents acquisition activity costs
Non-GAAP measures should not be considered a replacement for GAAP results. The non-GAAP measures indicated above are financial measures the Company uses to evaluate the underlying results and operating performance of the business. The limitation of these measures are that they exclude items that impact the Company's current period GAAP measures. This limitation is best addressed by using these measures in combination with the most directly comparable GAAP financial measures. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
We believe these measures enhance investors' ability to review the Company's business from the same perspective as the Company's management and facilitate comparisons of this period's results with prior periods.
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 7 of 8
AEHR TEST SYSTEMS
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
| May 31, |
|
|||||
| (In thousands, except par value) |
| 2024 |
|
| 2023 |
|
||
| ASSETS |
|
|
|
|
|
|
||
| Current assets: |
|
|
|
|
|
|
||
| Cash and cash equivalents |
| $ | 49,159 |
|
| $ | 30,054 |
|
| Short-term investments |
|
| - |
|
|
| 17,853 |
|
| Accounts receivable, net |
|
| 9,796 |
|
|
| 16,594 |
|
| Inventories |
|
| 37,470 |
|
|
| 23,908 |
|
| Prepaid expenses and other current assets |
|
| 1,423 |
|
|
| 621 |
|
| Total current assets |
|
| 97,848 |
|
|
| 89,030 |
|
| Property and equipment, net |
|
| 3,253 |
|
|
| 2,759 |
|
| Operating lease right-of-use assets, net |
|
| 5,734 |
|
|
| 6,123 |
|
| Deferred tax assets, net |
|
| 20,773 |
|
|
| - |
|
| Other non-current assets |
|
| 304 |
|
|
| 231 |
|
| Total assets |
|
| 127,912 |
|
|
| 98,143 |
|
| LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
| Current liabilities: |
|
|
|
|
|
|
|
|
| Accounts payable |
| $ | 5,332 |
|
| $ | 9,206 |
|
| Accrued expenses |
|
| 3,366 |
|
|
| 4,143 |
|
| Operating lease liabilities, short-term |
|
| 465 |
|
|
| 137 |
|
| Deferred revenue, short-term |
|
| 1,345 |
|
|
| 2,822 |
|
| Total current liabilities |
|
| 10,508 |
|
|
| 16,308 |
|
| Operating lease liabilities, long-term |
|
| 5,732 |
|
|
| 6,163 |
|
| Deferred revenue, long-term |
|
| 41 |
|
|
| 31 |
|
| Other long-term liabilities |
|
| 38 |
|
|
| 41 |
|
| Total liabilities |
|
| 16,319 |
|
|
| 22,543 |
|
|
|
|
|
|
|
|
|
|
|
| Shareholders equity: |
|
|
|
|
|
|
|
|
| Preferred stock, $0.01 par value: Authorized: 10,000 shares; |
|
|
|
|
|
|
|
|
| Issued and outstanding: none |
|
| - |
|
|
| - |
|
| Common stock, $0.01 par value: Authorized: 75,000 shares; |
|
|
|
|
|
|
|
|
| Issued and outstanding: 28,995 shares and 28,539 shares at May 31, 2024 and 2023, respectively |
|
| 289 |
|
|
| 285 |
|
| Additional paid-in-capital |
|
| 130,612 |
|
|
| 127,776 |
|
| Accumulated other comprehensive loss |
|
| (158 | ) |
|
| (155 | ) |
| Accumulated deficit |
|
| (19,150 | ) |
|
| (52,306 | ) |
| Total shareholders' equity |
|
| 111,593 |
|
|
| 75,600 |
|
| Total liabilities and shareholders equity |
| $ | 127,912 |
|
| $ | 98,143 |
|
Aehr Test Systems Reports Four Quarter and Full Year Financial Results
July 16, 2024
Page 8 of 8
| AEHR TEST SYSTEMS |
||||||||
| CONSOLIDATED STATEMENT OF CASH FLOWS |
||||||||
| (Unaudited) |
||||||||
|
|
| Year Ended May 31, |
|
|||||
| (In thousands) |
| 2024 |
|
| 2023 |
|
||
| Cash flows from operating activities: |
|
|
|
|
|
|
||
| Net income |
| $ | 33,156 |
|
| $ | 14,557 |
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
| 2,518 |
|
|
| 2,748 |
|
| Depreciation and amortization |
|
| 657 |
|
|
| 450 |
|
| Deferred income taxes |
|
| (20,773 | ) |
|
| - |
|
| Accretion of investment discount |
|
| (130 | ) |
|
| (576 | ) |
| Amortization of operating lease right-of-use assets (2) |
|
| 706 |
|
|
| 649 |
|
| Provision for credit loss |
|
| - |
|
|
| 24 |
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
| Accounts receivable |
|
| 6,790 |
|
|
| (3,788 | ) |
| Inventories |
|
| (13,732 | ) |
|
| (9,469 | ) |
| Prepaid expenses and other current assets |
|
| (875 | ) |
|
| 28 |
|
| Accounts payable |
|
| (3,891 | ) |
|
| 5,044 |
|
| Accrued expenses |
|
| (792 | ) |
|
| 528 |
|
| Deferred revenue |
|
| (1,469 | ) |
|
| 369 |
|
| Operating lease liabilities (2) |
|
| (423 | ) |
|
| (561 | ) |
| Income taxes payable |
|
| 14 |
|
|
| 8 |
|
| Net cash provided by operating activities |
|
| 1,756 |
|
|
| 10,011 |
|
|
|
|
|
|
|
|
|
|
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
|
| Proceeds from maturities of investments |
|
| 18,000 |
|
|
| 16,000 |
|
| Purchases of investments |
|
| - |
|
|
| (33,294 | ) |
| Purchases of property and equipment |
|
| (749 | ) |
|
| (1,362 | ) |
| Net cash provided by (used in) investing activities |
|
| 17,251 |
|
|
| (18,656 | ) |
|
|
|
|
|
|
|
|
|
|
| Cash flows from financing activities: |
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock under employee plans |
|
| 1,807 |
|
|
| 2,562 |
|
| Shares repurchased for tax withholdings on vesting of restricted stock units |
|
| (1,596 | ) |
|
| (2,060 | ) |
| Proceeds from issuance of common stock, net of issuance costs |
|
| (72 | ) |
|
| 6,820 |
|
| Net cash provided by financing activities |
|
| 139 |
|
|
| 7,322 |
|
|
|
|
|
|
|
|
|
|
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
| (41 | ) |
|
| (37 | ) |
|
|
|
|
|
|
|
|
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
|
| 19,105 |
|
|
| (1,360 | ) |
|
|
|
|
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash, beginning of year (1) |
|
| 30,204 |
|
|
| 31,564 |
|
| Cash, cash equivalents and restricted cash, end of year (1) |
| $ | 49,309 |
|
| $ | 30,204 |
|
|
|
|
|
|
|
|
|
|
|
| Supplemental cash flow information: |
|
|
|
|
|
|
|
|
| Income taxes paid |
| $ | 90 |
|
| $ | 21 |
|
| Interest paid |
| $ | - |
|
| $ | 15 |
|
|
|
|
|
|
|
|
|
|
|
| Supplemental disclosure of non-cash flow information: |
|
|
|
|
|
|
|
|
| Net transfer of equipment between inventory and property and equipment |
| $ | 357 |
|
| $ | 646 |
|
(1) Includes restricted cash in other non-current assets.
(2) Certain amounts in a prior period have been reclassified to conform to the current period presentation.